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Abstract
Background: Human T cells play an important role in pathogen clearance, but their aberrant activation is also linked to
numerous diseases. T cells are activated by the concurrent induction of the T cell receptor (TCR) and one or more
costimulatory receptors. The characterization of signaling pathways induced by TCR and/or costimulatory receptor
activation is critical, since these pathways are excellent targets for novel therapies for human disease. Although studies
using human T cell lines have provided substantial insight into these signaling pathways, no comprehensive, direct
comparison of these cell lines to activated peripheral blood T cells (APBTs) has been performed to validate their usefulness
as a model of primary T cells.
Methodology/Principal Findings: We used quantitative biochemical techniques to compare the activation of two widely
used human T cell lines, Jurkat E6.1 and HuT78 T cells, to APBTs. We found that HuT78 cells were similar to APBTs in
proximal TCR-mediated signaling events. In contrast, Jurkat E6.1 cells had significantly increased site-specific
phosphorylation of Pyk2, PLCc1, Vav1, and Erk1/Erk2 and substantially more Ca
2+ flux compared to HuT78 cells and
APBTs. In part, these effects appear to be due to an overexpression of Itk in Jurkat E6.1 cells compared to HuT78 cells and
APBTs. Both cell lines differ from APBTs in the expression and function of costimulatory receptors and in the range of
cytokines and chemokines released upon TCR and costimulatory receptor activation.
Conclusions/Significance: Both Jurkat E6.1 and HuT78 T cells had distinct similarities and differences compared to APBTs.
Both cell lines have advantages and disadvantages, which must be taken into account when choosing them as a model T
cell line.
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Introduction
Human T cells control the extent and focus of the adaptive
immune response to pathogens. T cells are activated by the
interaction of the cell surface, multi-subunit T cell receptor (TCR)
with an antigen-bound major histocompatibility complex present
on an antigen presenting cell [1,2]. In addition to TCR induction,
T cells also require an activating signal from one or more
costimulatory receptors, such as CD28 or the a4b1 integrin VLA-
4, to become fully active [1]. Costimulation is critical for the
specificity of the immune response because it allows T cells to be
activated only during acute infection. This enables the adaptive
immune system to mount a response to foreign invaders while
tolerating its own cells. The mistaken recognition of self leads to
aberrant T cell activation, resulting in numerous human disease,
such as autoimmune diseases, cardiovascular disease and allergies/
asthma [3,4,5]. Signaling pathways that are activated by
TCR and/or costimulatory receptors are good targets for the
development of therapies to these diseases [4,5]. However, before
effective therapies can be developed, we must first better
understand the intracellular signaling that occurs when a T cell
is activated.
An initial event upon TCR activation is the induction of the Src
family kinases Lck and Fyn, which then phosphorylate the
immunoreceptor tyrosine-based activation motifs (ITAMs) present
on several TCR subunits (Figure 1) [1]. The protein tyrosine
kinase ZAP-70 is recruited to the phosphorylated ITAMs and
activated upon phosphorylation of tyrosine 319 [1]. Activated Lck,
Fyn, and ZAP-70 then phosphorylate multiple downstream
substrates, including linker for activation of T cells (LAT) and
the tyrosine kinase Pyk2 [6,7,8]. Pyk2 is a member of the Fak
family of kinases and appears to control actin cytoskeletal
rearrangements that are critical for T cell activation [6]. LAT is
a hematopoietic-specific adaptor protein that mediates many
downstream events following TCR stimulation. Upon TCR
activation, LAT is phosphorylated on five conserved tyrosines,
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as the related adaptor proteins Grb2, Grap, and Gads, as well as
PLC-c1[8]. Once recruited to LAT, PLC-c1 is phosphorylated by
the Tec family tyrosine kinase Itk at tyrosine 783. This leads to the
increased ability of PLC-c1 to cleave phosphatidlyinositol (4,5)
bisphosphate into inositol (1,4,5) trisphosphate, which is important
for Ca
2+ influx, and diacylglycerol, which is important for protein
kinase C activation [9].
PLC-c1 and the Grb2 family of adaptor proteins all contain
SH3 domains that mediate the recruitment of signaling proteins to
LAT. Once such protein is SLP-76, an adaptor protein that is
brought to the LAT complex via its interaction with the adaptor
protein Gads and PLC-c1 (Figure 1) [10]. Upon TCR stimulation,
SLP-76 is phosphorylated and both Vav1 and Itk bind to these
phosphorylated tyrosines [10]. Vav1 is a guanine nucleotide
exchange factor for Rac, a small GTPase that triggers cytoskeletal
rearrangements downstream of TCR induction [11]. Vav1
requires the presence of Itk to bind phosphorylated SLP-76,
although it does not appear that Vav1 and Itk interact directly
[12]. Similarly, Itk requires binding to phosphorylated SLP-76 to
maintain its active conformation [13]. The end result of these
interactions at the LAT complex is the induction of important
downstream functions needed for T cell activation, such as Ca
2+
flux, Erk1/Erk2 activation, receptor upregulation and the
induction of cytokine release.
Much of our understanding of TCR-mediated signaling was
discovered using two human T cell lines, the Jurkat E6.1 T cell
and the HuT78 T cell. The original Jurkat cells were derived from
a 14-year-old boy with T cell acute lymphoblastic leukemia (T-
ALL). These cells are thymocytically derived with the character-
istics of immature thymocytes. The Jurkat E6.1 subclone cell line
was developed in the 1980s [14]. Sublines of Jurkat E6.1 cells have
been isolated that are deficient in several TCR signaling
molecules, including stable lines lacking the TCRb chain, Lck,
LAT, SLP-76, ZAP-70, Vav1, or PLC-c1 [14]. These mutants
have yielded much information and insight into the function of
many peripheral TCR signaling molecules. The HuT78 T cell line
is historically a very important cell line: the H9 subclone of HuT78
T cells is the cell used to isolate HIV. HuT78 cells were derived
from a Sezary syndrome patient, and are CD4+, mature,
cutaneous, lymphoid T cells [15].
Despite being highly useful for several reasons, such as mutant
sublines, high rates of transfection, and ease of growth, Jurkat E6.1
cells have several known abnormalities. These include deficiencies
Figure 1. Current model of proximal signaling pathways downstream of TCR activation. TCR activation leads to the induction of
numerous tyrosine kinases and adaptor proteins. The activation of these signaling molecules leads to morphological changes and alterations in
transcription that are vital for T cell activation and function. Proteins that are tyrosine phosphorylated upon TCR stimulation are identified with small
black circles.
doi:10.1371/journal.pone.0005430.g001
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inositide-3 kinase (PI3K) function [16,17]. The lack of PTEN and
SHIP leads to several irregularities including constitutive expres-
sion of AKT, increased levels of phosphorylated phosphoinositide
lipids, and the constitutive association of Itk with the plasma
membrane [17,18]. HuT78 cells also have deficiencies; they have
abnormal c-myc function and over express Bcl-xL, suggesting
problems with anti-apoptotic pathways in these cells [19,20].
Although all cell lines have inherent problems, there are many
reasons to use cell lines as model systems for studying the
activation and function of human T cells. Cell lines are useful
because they offer an unlimited, genetically manipulatable and
widely accessible supply of experimental material that can be
stored long-term and grown at a low cost. Using continuous cell
lines also reduces the human burden and ethical considerations of
experimentation and substantially reduces donor to donor
variation. It is important however, that the pros and cons of a
specific cell line are appreciated to allow for interpretation of
experiments using these cell lines. Surprisingly, there are no
previous studies that directly compare TCR and/or costimulatory-
mediated signaling and function in the human T cell lines to
human activated peripheral blood T cells (APBTs). Therefore, we
chose to compare the Jurkat E6.1 T cells and HuT78 T cells to
APBTs in an effort to determine the conduciveness of using these
T cell lines as a model for peripheral TCR signaling and function.
We found that there was no noteworthy difference among the
three cell lines when examining early signaling events such as
ZAP-70, LAT, and SLP-76 phosphorylation. However, there were
significant differences in downstream signaling events, costimula-
tory receptor expression and activation and in the cytokines and
chemokines released upon TCR induction. Advantages and
disadvantages exist for both cell lines, which must be considered
during the experimental design process.
Results
In order to compare proximal TCR-mediated signaling events
in Jurkat E6.1 T cells, HuT78 T cells, and APBTs, equal cell
numbers were activated with maximal doses of stimulatory TCR
antibodies. The samples were then analyzed by immunoblotting
using phosphospecific and pan antibodies to specific signaling
molecules. We calculated the ratio of phosphorylated protein to
total protein for each specific protein using quantified densities
from the immunoblots. By using this method, the total
phosphorylation per protein of a specific signaling molecule for
each cell type was determined, regardless of the size of the cell or
the concentration of protein present in each cell. Thus, the relative
extent of activation of key signaling molecules was compared
between each cell type.
Jurkat E6.1 T cells, HuT78 T cells, and APBTs had
significant differences in the phosphorylation of the
tyrosine kinases ZAP-70, but not the adaptor proteins
LAT and SLP-76
Before the relative activation of critical signaling molecules can
be assessed, the surface expression of the TCR ab chain in the
various T cell lines must be determined. This information is
needed because differences in the surface expression of the TCR
ab chain in Jurkat E6.1 T cells, HuT78 T cells and APBTs may
result in variations in receptor-mediated signaling events. To this
end, the surface expression of the TCR ab chain in the Jurkat
E6.1 T cells, HuT78 T cells and APBTs was examined by flow
cytometry. The mean fluorescent intensity (MFI) of the TCR ab
chain expression for three separate experiments was 78+/219 for
Jurkat E6.1 T cells, 29+/29 for HuT78 T cells and 60+/28 for
the APBTs (Figure 2 and data not shown). It was consistently
observed that HuT78 T cells had significantly less TCR ab chain
expression than Jurkat E6.1 T cells and APBTs, whereas there was
no significant difference in the expression of TCR ab chain
between the Jurkat E6.1 T cells and APBTs (Figure 2). Thus,
theHuT78 T cells have significantly less TCR surface expression
than the Jurkat E6.1 T cell and APBTs. However, whether this
difference leads to alterations in the extent of intracellular
signaling is unknown.
Upon engagement of the TCR with a specific peptide-MHC
complex, the tyrosine kinases ZAP-70 is phosphorylated and
activated by the Src family kinases Lck and Fyn [1]. Therefore, it
was of interest to determine if there were differences in the TCR-
induced phosphorylation of ZAP-70 among Jurkat E6.1 T cells,
HuT78 T cells and APBTs. Phosphorylation of ZAP-70 at tyrosine
residue 319 is required for its activation and subsequent
phosphorylation of the adaptor molecules LAT and SLP-76
[21,22]. The phosphorylation of this tyrosine is an excellent read-
out for enzymatically active ZAP-70. As seen in Figure 3, the
relative levels of tyrosine 319 phosphorylation were similar
between HuT78 T cells and APBTs. However, there was a
significant and reproducible 2–3 fold decrease in the site-specific
phosphorylation of ZAP-70 in Jurkat E6.1 T cells (Figure 3B). This
suggests that Jurkat E6.1 T cells have reduced levels of TCR-
induced ZAP-70 activation and potentially have altered down-
stream signaling.
We next examined the phosphorylation of signaling proteins
downstream of ZAP-70 to see if the diminished phosphorylation of
this important early kinase translated to later differences in TCR-
mediated signaling. ZAP-70 is the known kinase for the adaptor
proteins LAT and SLP-76 [23]. The phosphorylation of LAT at
tyrosine 191 is essential for the formation of multi-protein
signaling complexes that transmit the signal from the TCR
complex to downstream effectors [7,8]. When the relative levels of
LAT tyrosine 191 phosphorylation were examined, no differences
Figure 2. HuT78 T cells have less TCR surface expression than
Jurkat E6.1 T cells and APBTs. The surface expression of the TCR a/b
chain on Jurkat E6.1 T cells, HuT78 T cells, and APBTs was assessed by
flow cytometry. A representative plot of the TCR surface expression of
these cell lines is shown. The isotype control for each cell had a mean
fluorescent intensity of ,8. The experiment was repeated three times.
doi:10.1371/journal.pone.0005430.g002
Comparison of T Cell Lines
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5430were observed between Jurkat E6.1 and APBT samples or between
HuT78 and APBT samples (Figure 4A and 4B). However, there
was a small but significant difference in the phosphorylation of
LAT tyrosine 191 between Jurkat E6.1 and HuT78 T cell lines
(Figure 4A and 4B). These data show that the phosphorylation of
LAT is not substantially different among the cell lines, indicating
the binding capacity of LAT in each cell is similar.
Another important adaptor protein for functions downstream of
TCR activation is SLP-76. This protein is phosphorylated on three
tyrosine residues, including tyrosine 128. Phosphorylated SLP-76
is essential for bringing Vav1 and Itk to the LAT signaling
complex [10], which is vital for linking proximal TCR signaling to
events such as calcium influx and actin cytoskeletal rearrange-
ment. As seen for LAT, no difference was seen among the two cell
lines and APBTs in the phosphorylation of SLP-76 tyrosine 128
(Figure 4C and 4D), suggesting that SLP-76 has a similar signaling
capacity in each type of cell. Together, these data indicate that the
reduced levels of TCR a/b chain surface expression in the HuT78
T cells compared to other T cell lines and the decrease in ZAP-70
phosphorylation observed in Jurkat E6.1 T cells compared to
HuT78 T cells and APBTs does not translate into differences in
the activation of signaling proteins immediately downstream of
ZAP-70.
Jurkat E6.1 T cells have hyperphosphorylated PLC-c1 and
exhibited exaggerated Ca
2+ signaling compared to
HuT78 T cells and APBTs
Next, differences in several important signaling events down-
stream of LAT and SLP-76 were characterized in Jurkat E6.1 T
cells, HuT78 T cells, and APBTs. PLC-c1 activation is important
for both intracellular calcium flux and protein kinase C activation
[1,8]. Tyrosine 783 on PLC-c1 is phosphorylated by the Tec
family kinase Itk and is essential for PLC-c1 activation and
enzymatic function [13,24,25]. Therefore, the phosphorylation of
PLC-c1 tyrosine 783 was characterized to determine if there was a
difference in the phosphorylation of this important residue among
the T cell lines. Surprisingly, a 10-fold increase in the relative
phosphorylation of PLC-c1 tyrosine 783 was observed in the
Jurkat E6.1 T cell line, compared to the HuT78 T cells and
APBTs (Figure 5A and 5B). In contrast, no difference in the site-
specific phosphorylation of PLC-c1 was found between the
HuT78 T cells and APBTs (Figure 5A and 5B). This suggests
that PLCc1 is substantially more activated in Jurkat E6.1 T cells
compared to HuT78 T cells or APBTs.
The phosphorylation of tyrosine 775 on PLCc1 is also known to
be critical for TCR-induced Ca
2+ influx and transcription factor
activation [26]. Therefore, we examined whether the TCR-
mediated phosphorylation of this site is also increased in Jurkat
E6.1 T cells compared to other T cell lines. Interestingly, Jurkat
E6.1 T cells and APBTs had no detectable difference in the TCR-
induced phosphorylation of tyrosine 775 on PLCc1 (Figure 5C
and 5D). In contrast, HuT78 T cells had significantly less
phosphorylation of this site compared to both Jurkat E6.1 T cells
and APBTs (Figure 5C and 5D). This indicates that the
phosphorylation of tyrosines 775 and 783 on PLCc1, which are
both required for optimal TCR-induced function of this protein,
may be differentially regulated.
The observation that PLCc1 Y783 is hyperphosphorylated in
Jurkat E6.1 T cells compared to HuT78 T cells and APBTs lead us
to further examine the kinetics of PLC-c1 phosphorylation. This
was done in order to determine if the large differences in
phosphorylation were seen not only in the amount of TCR-
induced phosphorylation of PLC-c1 tyrosine 783 at a single
timepoint, but also in the timing and duration of this phosphor-
ylation event. A substantial difference was seen in the kinetics of
phosphorylation of PLC-c1 tyrosine 783 between Jurkat E6.1 T
Figure 3. Jurkat E6.1 T cells exhibit decreased ZAP-70 Y319 phosphorylation compared to HuT78 T cells and APBTs. (A) Three
samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific
phosphorylation and expression of ZAP-70 was assessed by immunoblotting using ZAP-70 pY319 (top) and pan-ZAP-70 (bottom) antibodies. (B) The
immunoblots were analyzed by densitometry and the ratio of the intensity of the phosphospecific ZAP-70 band to the pan-ZAP-70 band for each cell
line was averaged. Letters represents significant differences of p,0.05.
doi:10.1371/journal.pone.0005430.g003
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phosphorylation at 1 minute post-TCR stimulation, followed by a
steady decrease in phosphorylation over 30 minutes (Figure 6A).
APBTs and HuT78 T cells had similar TCR-induced phosphor-
ylation kinetics of PLC-c1 Y783 (data not shown). In contrast, the
Jurkat E6.1 T cell line reached maximal phosphorylation at
2 minutes and the phosphorylation of tyrosine 783 decreased only
slightly over the course of 30 minutes (Figure 6A). This indicates
that Jurkat E6.1 T cell have not only greater relative PLC-c1
tyrosine 783 phosphorylation than HuT78 T cells and APBTs, but
that they also sustain that level of hyperphosphorylation for a
much longer time.
The TCR-induced influx of Ca
2+ into human T cells is
controlled by PLC-c1 activation. The influx of Ca
2+ is important
Figure 4. Jurkat E6.1 T cells, HuT78 T cells, and APBTs have similar levels of LAT and SLP-76 phosphorylation. (A) Three samples of
Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation
and expression of LAT was assessed by immunoblotting using LAT pY191 (top) and pan-LAT (bottom) antibodies. (B) The immunoblots were analyzed
by densitometry and the ratio of the intensity of the phosphospecific LAT band to the pan-LAT band for each cell line was averaged. Letters
represents significant differences of p,0.01. (C) Three samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular
proteins were separated by SDS-PAGE. The site-specific phosphorylation and expression of SLP-76 was assessed by immunoblotting using SLP-76
pY128 (top) and pan-SLP-76 (bottom) antibodies. (D) The immunoblots were analyzed by densitometry and the ratio of the intensity of the
phosphospecific SLP-76 band to the pan-SLP-76 band for each cell line was averaged. There were no significant differences between cell lines and
p.0.25.
doi:10.1371/journal.pone.0005430.g004
Comparison of T Cell Lines
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and cytokine and chemokine production [1,27]. Due to its
importance in downstream T cell functions, we examined whether
the hyperphosphorylation of PLC-c1 in Jurkat E6.1 T cells lead to
alterations in the levels of TCR-induced Ca
2+ influx in the T cell
lines and APBTs. To this end, we utilized a quantitative, real-time
measurement method for intracellular Ca
2+ developed by Tsien
and coworkers [28]. Using this method, it was observed that both
cell lines and APBTs showed TCR inducible Ca
2+ influx
(Figure 6B). Jurkat E6.1 T cells exhibited approximately 7–10-
fold higher Ca
2+ flux immediately following stimulation than
HuT78 T cells or APBTs, as well as a higher level and longer time
of sustained Ca
2+ (Figure 6B). HuT78 T cells also showed higher
levels of initial Ca
2+ signaling than APBTs, although they returned
Figure 5. T cell lines have differences in PLCc1 phosphorylation. (A) Three samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were
stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and expression of PLCc1 was assessed by
immunoblotting using PLCc1 pY783 (top) and pan-PLCc1 (bottom) antibodies. (B) The immunoblots were analyzed by densitometry and the ratio of
the intensity of the phosphospecific PLC-c1 band to the pan-PLC-c1 band for each cell line was averaged. Letters represents significant differences of
p,0.0005. (C) Three samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE.
The site-specific phosphorylation and expression of PLCc1 was assessed by immunoblotting using PLCc1 pY775 (top) and pan-PLCc1 (bottom)
antibodies. (D) The immunoblots were analyzed by densitometry and the ratio of the intensity of the phosphospecific PLC-c1 band to the pan-PLC-c1
band for each cell line was averaged. Letters represents significant differences of p,0.03.
doi:10.1371/journal.pone.0005430.g005
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T cells (Figure 6B). These data indicate that the increased
phosphorylation of PLC-c1 tyrosine 783 in Jurkat E6.1 T cells also
translated into an amplification in Ca
2+ flux, as compared to
HuT78 and APBT cells.
Jurkat E6.1 T cells have hyperphosphorylated Pyk2 and
Vav1 compared to HuT78 T cells and APBTs
The intracellular tyrosine kinase Pyk2 is critical for integrating
receptor mediated signals that control the rearrangement of the
actin cytoskeleton [6]. The levels of the enzymatic activity of Pyk2
is controlled by the phosphorylation of tyrosine 580 in the
activation loop of the kinase domain [6]. Therefore, the
phosphorylation of this site can be used as a marker for the
induction of the kinase activity of Pyk2. To investigate the relative
activation of Pyk2 in Jurkat E6.1 T cells, HuT78 T cells, and
APBTs, the cells were stimulated for 1 minute (Jurkat E6.1 cells) or
30 seconds (HuT78 T cells and APBTs), which corresponded to
the maximal activation time of Pyk2 in these cell types (M. Collins
and J.C.D. Houtman, unpublished results). Interestingly, the
relative level of Pyk2 tyrosine 580 phosphorylation was signifi-
cantly different between Jurkat E6.1 T cells, HuT78 T cells and
APBTs, with Jurkat E6.1 T cells having the highest relative level of
Pyk2 tyrosine 580 phosphorylation and HuT78 T cells having the
lowest (Figure 7A and Figure 5B). These experiments show that
the enzymatic activity of Pyk2 is different in the individual T cell
lines, suggesting that there are differences in the ability of the TCR
to control the actin cytoskeleton between Jurkat E6.1 T cells,
HuT78 T cells and APBTs.
One potential mechanism for these differences is the
differential expression of PTP-PEST, a tyrosine phosphatase
known to dephosphorylate Pyk2 in T cells [29]. To investigate
this possibility, the expression of PTP-PEST in the three T cell
lines was characterized. Unfortunately, the expression of PTP-
PEST was not detectable in cell lysates (data not shown).
Therefore, PTP-PEST was immunoprecipitated from unstimu-
lated Jurkat E6.1 T cells, HuT78 T cells and APBTs. As seen in
Figure 7C, HuT78 T cells express PTP-PEST, whereas Jurkat
E6.1 T cells and APBTs have no detectable expression of this
phosphatase. These results agree with a recent study that also
observed the Jurkat E6.1 T cells and APBTs do not express PTP-
PEST [30]. These data suggest that the expression of PTP-PEST
in HuT78 T cells results in reduced levels of Pyk2 phosphory-
lation compared to APBTs. In contrast, the significant differences
in the TCR-induced phosphorylation of Pyk2 in Jurkat E6.1 T
cells and APBTs are not due to differential expression of this
phosphatase.
Vav1 is a guanine nucleotide exchange factor for the small
GTPase Rac1 and is important for receptor-mediated actin
cytoskeletal rearrangement in human T cells [11]. An obligate step
in the enzymatic activation of Vav1 is the phosphorylation of
tyrosine 174 [11]. In contrast to Pyk2, Vav1 tyrosine 174 had a
moderate 2-fold hyperphosphorylation in Jurkat E6.1 T cells
compared to both HuT78 T cells and APBTs (Figure 8A and
Figure 6B). These data suggest that Vav1 is hyperactivated in
Jurkat E6.1 T cells, which, in conjunction with the hyperpho-
sphorylation of Pyk2, indicates a potential distortion of cytoskeletal
rearrangement in these cells.
Figure 6. Jurkat E6.1 T cells have increased PLCc1 function compared to HuT78 T cells and APBTs. (A) Jurkat E6.1 T cells and HuT78 T
cells were stimulated over a 309 time course and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and expression
of PLCc1 and the expression of actin was assessed by immunoblotting using PLCc1 pY783 (top) and pan-PLCc1 (bottom) antibodies. (B) TCR-induced
calcium flux was measured quantitatively as described above. Traces for Jurkat E6.1 T cells, HuT78 T cells and APBTs are shown.
doi:10.1371/journal.pone.0005430.g006
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The hyperphosphorylation of both Vav1 and PLC-c1a t
important tyrosine residues, as well as exaggerated Ca
2+ flux, in
Jurkat E6.1 T cells led us to examine Itk, the common link among
these events. Itk requires Vav1 to bind SLP-76, an event necessary
for Itk to phosphorylate PLC-c1 Y783 [12]. Phosphorylation of
tyrosine residue 511 is required for the activation of Itk [31],
therefore the phosphorylation of this site serves as a marker for the
induction of Itk kinase activity. Unfortunately, we were unable to
directly detect any TCR-induced site-specific phosphorylation of
Itk in stimulated T cell lysates (data not shown). Consequently, Itk
immunoprecipitations were performed to examine differences in
the phosphorylation of Itk tyrosine 511. Interestingly, there was
observable TCR-induced phosphorylation of Itk tyrosine 511in
Jurkat E6.1 T cells, but little detectable phosphorylation of this site
in HuT78 T cells and APBTs (Figure 9A and Figure 7B). In
addition, there was an increase in the amount of immunoprecip-
itated Itk in Jurkat E6.1 T cells compared to HuT78 T cells and
APBTs (Figure 9A), suggesting Jurkat E6.1 cells have increased
expression of Itk. To more directly compare expression of Itk in
the T cell lines, the levels of Itk in an equal cell number of Jurkat
E6.1 T cells and HuT78 T cells, and APBTs was measured by
immunoblotting. Jurkat E6.1 T cells had at least a 2-fold greater
Itk expression than HuT78 T cells (Figure 9C). Jurkat E6.1 T cells
from different laboratories had differences in the relative levels of
Itk, with most having increased levels of this protein. This suggests
that there are variations in the relative levels of signaling proteins
in individual sublines of the Jurkat E6.1 T cells. Collectively, these
data indicate that the increased expression of Itk in Jurkat E6.1 T
cells compared to HuT78 T cells and APBTs is linked to
exaggerated TCR-mediated signaling.
Figure 7. Jurkat E6.1 T cells, HuT78 T cells, and APBTs have different levels of Pyk2 Y580 phosphorylation. (A) Three samples of Jurkat
E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and
expression of Pyk2 was assessed by immunoblotting using Pyk2 pY580 (top) and pan-Pyk2 (bottom) antibodies. (B) The immunoblots were analyzed
by densitometry and the ratio of the intensity of the phosphospecific Pyk2 band to the pan-Pyk2 band for each cell line was averaged. Letters
represents significant differences of p,0.05. (C) PTP-PEST was immunoprecipitated for Jurkat E6.1 T cells, HuT78 T cells and APBTs. The expression of
PTP-PEST in the different T cells was assessed by immunoblotting.
doi:10.1371/journal.pone.0005430.g007
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Erk2 compared to HuT78 T cells and APBTs
The MAP kinases Erk1 and Erk2 are important for the
regulation of the expression and function of the transcription
factor AP-1 [1]. The activation of these kinases is downstream of
LAT phosphorylation, Vav1 activation, and Ca
2+ influx [1]. The
phosphorylation of Erk1 and Erk2 on threonine 202 and tyrosine
204 in the activation loop of their kinase domain is required for full
enzymatic activity of these proteins. Thus, the dual phosphoryla-
tion of these sites is a measure of the enzymatic activity of these
kinases. Due to its important role in linking cytoplasmic signaling
events to changes in gene transcription, the phosphorylation of
Erk1 and Erk2 was determined in the three T cell lines. A
significant increase in the TCR-induced phosphorylation of Erk1
and Erk2 was observed in Jurkat E6.1 T cells compared to HuT78
T cells and APBTs (Figure 10A and 10B). This is consistent with
the increase in the phosphorylation of other important signaling
molecules in Jurkat E6.1 cells and indicates that these T cells have
exaggerated distal signaling events compared to HuT78 T cells
and APBTs.
Jurkat E6.1 T cells, HuT78 T cells, and APBTs have distinct
patterns of TCR-induced cytokine release and
costimulatory receptor expression and function
TCR activation leads to the increased production and release of
numerous cytokines and chemokines that affect the function and
localization of immune cell types. Because of the importance of
cytokines and chemokines in the host immune response, we
examined the release of these molecules from Jurkat E6.1 T cells,
HuT78 T cells and APBTs upon TCR activation. For these
studies, the T cell lines were stimulated for 24 hours using plate-
bound stimulatory anti-TCR antibody and the release of 28
chemokines and cytokines was quantitatively measured using a
cytokine multiplex assay. As seen in Table 1, APBTs released a
wide range of cytokines and chemokines upon TCR stimulation.
These include Th1- and Th2-associated cytokines and chemokines
and the Th17 associated cytokine, IL-17 (Table 1) [32,33,34,35].
The release of such a wide range of cytokines and chemokines was
due to the varied nature of the APBTs, which contain mixture of
CD4+ and CD8+ T cells. In contrast, Jurkat E6.1 T cells release a
more limited pool of cytokines and chemokines, with only IL-2
and the chemokines, IL-8, MIP-1a, MIP-1b and MCP-1 being
produced in detectable quantities (Table 1). HuT78 T cells
released a wider range of chemokines and cytokines than Jurkat
E6.1 T cells, including a mixture of Th1-and Th-2 associated
chemokines and cytokines. These data suggest that HuT78 T cells
are more similar to APBTs than Jurkat E6.1 T cells in their TCR-
induced production of cytokines and chemokines.
One important cytokine produced by TCR-stimulated T cells is
IL-2, which controls T cell growth and differentiation [34]. As IL-
2 production is considered an excellent way to measure cumulative
activation of a T cell and it was the only cytokine produced by all
three cell lines, we decided to examine the production of IL-2 by
TCR-stimulated Jurkat E6.1 T cells, HuT78 T cells, and APBTs.
For these studies, the T cell lines were stimulated with plate-bound
stimulatory TCR antibody alone or in combination with soluble
stimulatory CD28 antibody or plate-bound fibronectin, the ligand
for VLA-4. These activators were chosen to investigate the
coordinate induction of two well studied costimulatory receptors,
CD28 and the VLA-4 integrin, and the TCR. To this end, APBTs
produced IL-2 when stimulated with TCR antibody, but co-
treatment with either CD28 antibody or fibronectin lead to a
significant 106–126-fold increase in IL-2 production (Figure 11).
There was no significant difference between the IL-2 production
in APBTs costimulated with either the CD28 antibody or
fibronectin (Figure 11). Jurkat E6.1 T cells also produced IL-2
in response to TCR antibody treatment and had approximately
Figure 8. Jurkat E6.1 T cells exhibit hyperphosphorylated of Vav1 Y174 compared to HuT78 T cells and APBTs. (A) Three samples of
Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation
and expression of Vav1 was assessed by immunoblotting using Vav1 pY174 (top) and pan-Vav1 (bottom) antibodies. (B) The immunoblots were
analyzed by densitometry and the ratio of the intensity of the phosphospecific Vav1 band to the pan-Vav1 band for each cell line was averaged.
Letters represents significant differences of p,0.005.
doi:10.1371/journal.pone.0005430.g008
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antibody (Figure 11). In contrast, costimulation of Jurkat E6.1 T
cells with fibronectin resulted in a small, but not significant,
increase in IL-2 production over TCR stimulation alone. HuT78
T cells showed no statistically significant increase in IL-2
production when co-treated with the CD28 antibody or
fibronectin compared to TCR antibody alone (Figure 11). It is
of note, however, that both Jurkat E6.1 T cells and HuT78 T cells
consistently produced substantially more IL-2 than APBTs upon
treatment with similar concentrations of TCR antibody alone,
suggesting both cell lines have increased expression of IL-2 upon
TCR activation.
To further investigate the surprising unresponsiveness of Jurkat
E6.1 and HuT78 T cells to CD28 and/or VLA-4-mediated
signals, we characterized the expression of several critical cell
surface receptors on Jurkat E6.1 T cells, HuT78 T cells, and
APBTs by flow cytometry. As expected, all three cell lines had high
expression of the TCR (Table 2). In contrast, there was variable
expression of the co-receptor CD4. Jurkat E6.1 T cells had little to
no detectable CD4 expression whereas the majority of HuT78 T
cells had a low but detectable expression of this protein (Table 2).
APBTs had substantial percentage of cells that expressed CD4,
with levels between 50%–80% depending on the donor (Table 2).
All three cells lines had high surface levels of the costimulatory
receptor CD7 and the integrins LFA-1 and VLA-4 (Table 2).
Interestingly, Jurkat E6.1 T cells and APBTs also had substantial
expression of the costimulatory receptors CD28 and CD2,
whereas HuT78 T cells had no detectable expression of these
molecules (Table 2). APBTs expressed both the activation-induced
receptors CD44 and CD137 (Table 2), as expected since these cells
were stimulated upon expansion. In contrast, Jurkat E6.1 cells had
no detectable levels of either CD44 or CD137 (Table 2).
Interestingly, HuT78 T cells had low but detectable levels of
CD44 but did not expression CD137 in the unactivated state
(Table 2). However, TCR stimulation could upregulated CD137
in HuT78 T cells but not in Jurkat E6.1 T cells (data not shown).
These data show that Jurkat E6.1 T cells, HuT78 T cells and
APBTs have different patterns of costimulatory receptor expres-
sion, indicating that Jurkat E6.1 and HuT T cells would be
distinctly useful for the study of costimulatory receptors. In
addition, these data suggest that the unresponsiveness of HuT78 T
cells to CD28 stimulatory signals is due the lack of surface
Figure 9. Jurkat E6.1 T cells have increased expression and TCR-induced phosphorylation of Itk compared to HuT78 T cells and
APBTs. (A) Itk was immunoprecipitated from lysates for TCR-induced Jurkat E6.1 T cells, HuT78 T cells, and APBTs and the cellular proteins were
separated by SDS-PAGE. The site-specific phosphorylation and expression of Itk was assessed by immunoblotting using Itk pY511 (top) and pan-Itk
(bottom) antibodies. (B) The immunoblots were analyzed by densitometry and the ratio of the intensity of the phosphospecific Itk band to the pan-Itk
band for each cell line for three separate experiments was averaged. Letters represents significant differences of p,0.04. (C) Whole cell lysates of
Jurkat E6.1 T cells and HuT78 T cells were prepared and immunoblotted using pan-Itk (top) and actin (bottom) antibodies.
doi:10.1371/journal.pone.0005430.g009
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E6.1 and HuT78 T cells to fibronectin is unknown, since both cell
lines express VLA-4 on their surface.
Discussion
The inappropriate activation or suppression of T cells can be
implicated in nearly all human diseases, including cancer, heart
disease, multiple sclerosis, asthma, allergies, diabetes, and many
others [3,4,36,37,38]. Early signaling pathways induced by both
the TCR and/or costimulatory receptors are excellent targets for
therapies to these diseases. Although a great deal is known about
the induction of signaling by these receptors, much more must be
learned before therapies can be effectively developed to target
these pathways. T cell lines are an integral part of the research of
T cell signaling due to their ease of use, low cost, and reduced
human burden. However, not all cell lines are equally useful as a
model system of human T cells. In this paper, we investigated
differences in peripheral TCR signaling, cytokine release and
costimulatory receptor function and expression among the Jurkat
E6.1 T cell line, the HuT78 T cell line, and APBTs.
To examine the relative extent of activation of key signaling
molecules in Jurkat E6.1 T cells, HuT78 T cells, and APBTs, we
used a previously described method for quantifying the amount of
phosphorylation per protein present in an activated T cell [24,39].
By using this method, the total phosphorylation per protein of a
specific signaling molecule for each cell type was determined and
compared, regardless of the total amount of protein present. This
is important since there were substantial differences between the T
cell lines and APBTS in the expression of several of the examined
signaling proteins, including ZAP-70, Pyk2 and Vav1. By
normalizing the phosphorylation level of each protein to the
absolute amount expressed in each cell type, we were able to
eliminate potential artifacts due to differences in expression levels.
The first signaling event to occur upon TCR activation is the
stimulation of the Src family kinases Lck and Fyn [1]. We
investigated the phosphorylation of Lck and Fyn at the activating
tyrosine residue 394 and 420, respectively, and found that these
sites had constitutive phosphorylation in Jurkat E6.1 T cells, but
moderate TCR-inducible phosphorylation in HuT78s and APBTs
(data not shown). However, the low level of inducible phosphor-
ylation of Lck and Fyn made the immunoblots difficult to quantify
using the described method. These differences in the regulation of
Lck and Fyn did not appear to matter since only a slight decrease
was seen in the phosphorylation of tyrosine 319 on the tyrosine
kinase ZAP-70 in Jurkat E6.1 T cells compared to HuT78 T cells
and APBTs (Figure 3). This difference in ZAP-70 activation did
not translate into changes in the phosphorylation of the ZAP-70
substrates, LAT and SLP-76 (Figure 4). Together, these results
indicate that although there are small differences in events
immediately following TCR activation, the relative levels of
activated LAT and SLP-76 in each cell type remains the same.
The similarities between Jurkat E6.1 T cells, HuT78 T cells and
APBTs ended at signaling events downstream of LAT and SLP-
76. Jurkat E6.1 T cells have deficiencies in the expression of lipid
phosphatases PTEN and SHIP, leading to the constitutive
activation of AKT, a serine-threonine kinase important for cell
survival, and other downstream signaling molecules [16,17,18]. In
addition to this defect, we observed three new defects in Jurkat
E6.1 T cells compared to APBTs. First, Jurkat E6.1 cells have a
significant increase in the relative phosphorylation of PLCc1
tyrosine 783 compared to HuT78 T cells and APBTs (Figure 5). In
contrast, HuT78 T cells had reduced levels of PLCc1 tyrosine 775
phosphorylation compared to Jurkat E6.1 and APBTs (Figure 5).
Interestingly, these data indicate these two sites on PLCc1 may
have differential regulation by intracellular kinases and phospha-
tases. The end result of alterations in PLCc1 phosphorylation in
the various cell lines was that Jurkat E6.1 T cells exhibited a nearly
Figure 10. Jurkat E6.1 T cells have hyperphosphorylated Erk1/Erk2 compared to HuT78 T cells and APBTs. (A) Three samples of Jurkat
E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and
expression of Erk1 and Erk2 was assessed by immunoblotting using Erk1/Erk2 pT202/pY204 (top) and pan-Erk1/Erk2 (bottom) antibodies. (B) The
immunoblots were analyzed by densitometry and the ratio of the intensity of the phosphospecific Erk1/Erk2 bands to the pan-Erk1/Erk2 bands for
each cell line for three separate experiments was averaged. Letters represents significant differences of p,0.005.
doi:10.1371/journal.pone.0005430.g010
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2+ flux than HuT78 T cells and
APBTs (Figure 6). In addition, Jurkat E6.1 T cells also had
increased levels of site-specific phosphorylation of Vav1 and Erk1/
Erk2 (Figure 8 and Figure 10).
The reason for the distorted phosphorylation of PLCc1 and
Vav1 does not appear to be due to deficiencies in the expression of
PTEN and SHIP, since we have recently shown that inhibition of
PI3K does not alter the site specific phosphorylation of these
proteins (NCO and JCDH, manuscript submitted). The hyperpho-
sphorylation of Erk1/Erk2 and the increased levels of TCR-
induced Ca
2+ influx could, in part, be due to decreased expression
of PTEN and SHIP, because PI3K signaling is needed for the
optimal activation of these events in human T cells (NCO and
JCDH, manuscript submitted). However, a probable mechanism
for this distorted signaling appears to involve Itk, which had both
higher levels of expression and phosphorylation at tyrosine 511 in
Jurkat E6.1 T cells than in HuT78 T cells and APBTs (Figure 9).
There was some variation in the Itk expression levels in various
sublines of Jurkat E6.1 T cells, with most expressing high levels of
Itk (data not shown). This indicates that genetic drift in the various
sublines of this T cell line leads to differences in the expression of
intracellular signaling proteins. Importantly, this is the first time
that the over-expression of Itk, an crucial molecule at the
intersection of TCR and costimulatory receptor-mediated signal-
ing in T cells [40], has been observed in Jurkat E6.1 cells.
Next, we found that Pyk2 was hyperphosphorylated in TCR-
stimulated Jurkat E6.1 T cells compared to HuT78 T cells and
APBTs (Figure 7). Again, this is the first description of the
increased phosphorylation of Pyk2 in Jurkat E6.1 T cells. The
mechanism for the increased phosphorylation of Pyk2 is unknown,
but does not appear to be due to alterations in the expression of
PTP-PEST. Pyk2 is important since it integrates receptor signals
controlling actin cytoskeletal rearrangement [6]. The increased
relative phosphorylation of Pyk2, in conjunction with the
augmented phosphorylation of Vav1 (Figure 8), suggests that the
actin cytoskeletal rearrangement in Jurkat E6.1 T cells may be
altered compared to HuT78 T cells and APBTs.
Finally, Jurkat E6.1 T cells release substantially fewer cytokines
and chemokines upon TCR activation than HuT78 T cells and
APBTs (Table 1). However, the amount of IL-2 and IL-8 released
by Jurkat E6.1 T cells is substantially greater than the levels of
these hormones produced by APBTs. These differences are likely
due to the thymocytic origin of the Jurkat E6.1 T cells and the fact
that the cells were selected for their ability to produce large
amounts of IL-2 [14].
Although this study suggests that Jurkat E6.1 T cells differ in
signaling from APBTs, they do have advantages (Table 3). The
cells are incredibly resilient and easy to grow and maintain. There
are also many useful mutant lines of Jurkat E6.1 T cells, each
lacking a specific molecule in the peripheral TCR signaling
pathway. Jurkat E6.1 T cells are remarkably easy to transfect, with
transfection efficiencies routinely reaching 80–90%. Finally, a
hidden advantage pointed to in this study is that they have
exaggerated signaling, making changes much easier to detect.
Even with the increased proximal signaling, studies using Jurkat
E6.1 are likely valid since many of the discoveries and observations
initially found in Jurkat E6.1 T cells have been subsequently
shown in APBTs. Together, the data show that although the
Jurkat E6.1 T cell line has substantially altered TCR-induced
signaling, this cell line can still be a useful model for TCR signaling
if deficiencies and problems are taken into account and the results
are confirmed in APBTs.
Conversely, this study points to the many similarities between
HuT78 T cells and APBTs. One significant difference in the
relative levels of early TCR-induced signaling events between
HuT78 T cells and APBTs was the reduced TCR-induced
phosphorylation of Pyk2 in HuT78 T cells (Figure 7). This is likely
due to the expression of PTP-PEST, a known phosphatase for
Pyk2, in HuT78 T cells and not activated APBTs. However, this
difference may be less important than it seems, since a recent study
has shown that PTP-PEST is expressed in naı ¨ve primary T cells
and not activated T cells, the subtype of APBTs used for these
studies [30]. In addition, HuT78 T cells produce a greater number
of cytokines and chemokines upon TCR stimulation than Jurkat
E6.1 T cells. Finally, HuT78 T cell can express several
costimulatory receptors found in activated T cells, allowing
investigation of these costimulatory pathways in a model T cell
line. HuT78 T cells also have disadvantages, however. They do
not express the costimulatory receptors CD2 or CD28 (Table 2),
and are unable to be co-stimulated by fibronectin, suggesting that
although VLA-4 is expressed, it may not be functional in these
cells (Figure 11). In addition, HuT78 cells have elevated levels of
IL-2 production without costimulation as compared to APBTs
Table 1. TCR-induced release of cytokines and chemokines
from Jurkat E6.1 T cells, HuT78 T cell, and APBTs.
Cytokine Jurkat E6.1 HuT78 APBT
IL-1b -- -
IL-2 +++ +++ +/++
IL-4 - - +
IL-5 - - +
IL-6 - - -
IL-7 - - ++
IL-8/CXCL8 +++ - +/++
IL-10 - +++ +/++
IL-12 - ++
IL-13 - ++ /++
IL-15 - - -
IL-17 - - +
VEGF - ++ ++
TNF-a -- ++
IFN-a -- - / +
IFN-c -- ++
GM-CSF - ++ ++/+++
MIP-1a/CCL3 ++ + +++
MIP-1b/CCL4 ++ ++ +++
IP-10/CXCL10 - + -
MIG/CXCL9 - ++
Eotaxin/CCL11 - - -
RANTES/CCL5 - +++ ++/+++
MCP-1/CCL2 ++ - ++
G-CSF - ++ +/++
EGF - - -
Basic FGF - ++
HGF - - -
- no detectable release.
+,100 pg/mL.
++ 101–999 pg/mL.
+++.1000 pg/mL.
doi:10.1371/journal.pone.0005430.t001
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over express Bcl-xL, which indicates possible problems with the
anti-apoptotic pathway in these cells [19,20]. All of this
information must be kept in mind when choosing to use HuT78
T cells as a model system for T cell biology.
The results of this study indicate that HuT78 T cells are similar
to APBTs in peripheral TCR signaling, whereas Jurkat E6.1 T
cells exhibit exaggerated signaling (Table 3). In addition, there
were differences in cytokine release and costimulatory receptor
expression and function between the various cell lines. These
results are significant in that, for the first time, a direct comparison
of commonly used cell lines and APBTs has been performed.
Though it is clear that APBTs are the ideal cells to use for
examining TCR signaling, this is not always feasible. Both Jurkat
E6.1 T cells and HuT78 T cells have advantages and
disadvantages, but HuT78 T cells are clearly the most like APBTs
in the phosphorylation of important peripheral TCR signaling
molecules and cytokine release. The relative advantages and
disadvantages of each cell line must be taken into account when
choosing a model cell line for individual experiments.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of University of Iowa. All donors
provided written informed consent for the collection of samples
and subsequent analysis.
Materials
RPMI 1640, Iscoves Modified Dulbecco’s Media (IMDM), L-
Glutamine, Penicillin-streptomycin, and PBS were purchased from
Gibco. Fetal Bovine Serum (FBS) was acquired from Atlantic. Src
family kinase pY416, pan-Lck, ZAP-70 pY319 (65E4), pan-ZAP
(99F2), p44/42 MAPK and pan-PLCc1 antibodies were bought
from Cell Signaling Technology. LAT pY191, pan-LAT, mouse
Figure 11. Jurkat E6.1 T cells and HuT78 T cells have aberrant IL-2 production compared to APBTs. Jurkat E6.1 T cells, HuT78 T cells and
APBTs were stimulated using a CD3 antibody (1 mg/mL), both alone and in combination with a stimulatory CD28 antibody (2 mg/mL) and fibronectin
(1 mg/mL). The production of IL-2 after 24 hours of stimulation was assessed by ELISA as described above.
doi:10.1371/journal.pone.0005430.g011
Table 2. Expression of surface receptors in Jurkat E6.1 T cells,
HuT78 T cell, and APBTs.
Receptor Jurkat E6.1 HuT78 APBT
TCR +++ +++ +++
CD4 - ++ ++/+++
CD28 +++ - +++
CD2 +++ - +++
CD7 +++ +++ +++
CD11a/LFA-1 +++ +++ +++
CD49d/VLA-4 +++ +++ +++
CD44 - ++
CD137/4-1BB - - +
+++.75%.
++50–75%.
+25–50%.
-,25%.
doi:10.1371/journal.pone.0005430.t002
Table 3. Phosphorylation per protein in Jurkat E6.1 and
HuT78 cell lines as compared to APBTs.
Protein Jurkat E6.1 HuT78
ZAP-70 Y319 , =
LAT Y191 = =
SLP-76 Y128 = =
PLCc1 Y783 . =
PLCc1 Y775 = ,
Vav1 Y174 . =
Pyk2 Y580 .,
Erk 1/2 Y . =
, indicates significantly less phosphorylation per protein than APBTs.
. indicates significantly more phosphorylation per protein than APBTs.
= indicates no significant difference in phosphorylation per protein as
compared to APBTs.
doi:10.1371/journal.pone.0005430.t003
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pY128, Itk pY511, TCR a chain and CD4 antibodies were
purchased from BD Pharmingen. Pan-Vav1 (C-14), all secondary
antibodies, and protein A/G agarose beads were acquired form
Santa Cruz Biotechnologies, Inc. The PLCc pY783 and Erk1/
Erk2 pY1857/187 antibodies and the human cytokine 30-plex
luminex kit were bought from Biosource/Invitrogen. The PLCc
pY775 antibody was a gift of Dr. Barbara Rellahan. The pan-SLP-
76 antibody was obtained from Antibody Solutions. The Vav1
pY174 antibody was purchased from Abcam, Inc. The pan-Itk
antibody was acquired from Chemicon International. OKT3 was
produced from hybridoma. CD2, CD4, CD7, CD11a, CD28,
CD44, CD49d and CD137 antibodies were purchased from
Biolegend. The pan human IL-2 antibodies were obtained from
Ebiosciences. IL-2 was obtained from R&D Systems. Criterion
Precast polyacramide gels (4–15% and 15% Tris-HCl) were
purchased from Biorad. Immobilon PVDF Transfer Membrane
was acquired from Millipore. Indo-1-AM was purchased from
Invitrogen. All chemicals used were research grade and purchased
from various sources.
Cell line stimulation
The Jurkat E6.1 T cells were a kind gift of Dr. Lawrence
Samelson. Jurkat E6.1 T cells were grown at 37uCi n5 %C O 2
using complete RPMI 1640 media (RPMI 1640 supplemented
with 10% FBS, 2 mM L-glutamine, 50 U/mL penicillin, and
50 mg/mL streptomycin). HuT78 T cells were purchased from
ATCC. HuT78 T cells were grown in IMDM media supplement-
ed with 10% FBS, 2 mM L-glutamine, 50 U/mL penicillin, and
50 mg/mL streptomycin. Both cell lines were grown to a
concentration of 2–5610
5 cells/mL. Cells were washed with
RPMI 1640 before use and then resuspended at a density of
5610
7 cells/mL. Each sample of 4610
6 cells was then treated with
10 mg/mL CD3 antibody (OKT3) for various times. Samples were
lysed with 4-fold excess hot 26 sample buffer (20 mM Tris
pH 8.0, 2 mM EDTA, 2 mM Na3VO4, 20 mM DDT, 2% SDS,
and 20% glycerol), heated at 95uC for 4 minutes, and sonicated to
reduce viscosity.
APBT isolation and stimulation
All the studies described below were approved by the Human
Subjects Institutional Review Board at the University of Iowa.
Healthy blood donors were recruited by word-of-mouth from the
students and staff of biomedical laboratories at the Carver College
of Medicine at the University of Iowa. Informed consent was
obtained from all donors before commencement of blood draws.
Peripheral blood T cells were isolated from the venous blood of
healthy human donors as previously described [24]. The cells were
then grown in culture for 5–7 days in complete RPMI 1640 media
supplemented with 10 ng/mL IL-2. After incubation, the T cells
were .90% positive for TCR a/b chains and .97% positive for
CD28, CD2, CD7, CD11a and CD49d. Depending on the donor,
the T cells were 30–70% positive for CD4, with the typical donor
having ,65% CD4 positive T cells.
To stimulate the cells, the T cells were washed with RPMI 1640
and resuspended to a concentration of 1610
8 cells/mL. After a
short incubation on ice, cells were treated with 10 mg/mL CD3
(OKT3) and 10 mg/mL CD4 antibodies and returned to ice for
30 minutes. Both CD3 and CD4 antibodies were used since only
concurrent stimulation with these antibodies, and not CD3
antibody treatment alone, could induce detectable TCR-mediated
signaling [24]. The cells were warmed at 37uC for 10 minutes and
immediately stimulated with 25 mg/mL mouse specific goat IgG
antibody for various times. Samples were lysed with a 2-fold excess
of hot 26 sample buffer, heated for 4 minutes at 95uC, and
sonicated to reduce viscosity.
Immunoblotting
The protein components of 2610
5 cell equivalents/ sample
were separated by SDS-PAGE using 4–15% or 15% Criterion
pre-cast polyacrylamide gels. The separated proteins were then
transferred to PVDF and blocked with 5% milk in TBST for
45 minutes at room temperature. The membranes were then
incubated at room temperature with primary antibody diluted in
5% milk for 1 hour, followed by the appropriate secondary
antibody diluted in 5% milk for 30 minutes. The immunoblots
were then visualized by chemiluminescence using a Fuji imager.
Analysis of immunoblotting
Immunoblots were analyzed using NIH Image J. The ratio of
phosphospecific to pan expression of each protein was determined
for stimulated and unstimulated samples in each cell type, allowing
the determination of the phosphorylation per protein in each cell.
Stimulated sample ratios for each cell type were then averaged and
compared to the other cell types using a two-tailed t-test assuming
equal variance. Whole cell lysate samples used to compare Itk
expression were also analyzed using NIH Image J and normalized
using actin expression. The ratio of protein: actin was compared
between cell lines using a two-tailed t-test assuming equal variance.
Immunoprecipitations
Jurkat E6.1 T cells, HuT78 T cells, and APBTs were grown as
indicated above. The cells were washed in RPMI 1640 and
resuspended to a concentration of 5610
7 cells/mL. 100 mLo f
cells/sample were stimulated as described above for various times
and lysed in 400 mL lysis buffer (25 mM TRIS pH 8.0, 150 mM
NaCl, 1% Brij 97, 0.5% n-Octyl-beta-D-glucopyranoside, 5 mM
EDTA, 1 mM Na3VO4, and protease inhibitor). Samples were
incubated on ice with mixing for 20 minutes and centrifuged.
Supernatant was added to 20 mL protein A/G agarose beads and
rotated at 4uC for 30 minutes. Beads were pelleted and the
supernatant was applied to 25 mL protein A/G agarose beads and
2 mg anti-Itk antibody and rotated at 4uC overnight. Pelleted
beads were washed 4 times with 800 mL lysate buffer
(25 mMTRIS pH 8.0, 150 mM NaCl, 1% Brij 97, and 0.5%
octyl glucoside) and then the bound proteins were eluted with
30 mL hot 26 sample buffer. Samples were heated at 95uC for
4 minutes.
Calcium influx
Calcium influx was measure quantitatively as previously
described [34,35]. Briefly, Jurkat E6.1, HuT78, and APBTs were
grown as indicated above. The cells were washed in RPMI 1640
without phenol red and resuspended to a concentration of 1610
6
cells/mL in 1 mL RPMI 1640 without phenol red, 1 mM
probenecid, and 5 mM indo-1-AM. The cells were incubated for
1 hour at 37uC. After incubation the cells were washed twice with
RPMI 1640 without phenol red. The pellet was then resuspended
in RPMI 1640 without phenol red and 1 mM probenecid. The
cells were kept on ice and in the dark until use.
Measurements were done at 37uC with constant stirring in
acrylic cuvettes using a Fluorolog fluorimeter. The cells were
excited at 350 nm and emission was measured at l1=405 nm and
l2=485 nm. Fluorescence at l1 and l2 was measured in
unstimulated cells every 10 seconds for a total of 60 seconds.
The cells were then stimulated with 10 mg/mL CD3 antibody and
fluorescence at l1 and l2 measured every 10 seconds for a total of
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florescence was measured at both l1 and l2. 2 mM EGTA was
then added to sequester the Ca
2+ from the dye and again,
fluorescence was measured at both emission wavelengths. Ca
2+
influx was then determined using the equation [Ca
2+]=KD[(R2R-
min)/Rmax2R)](Sf2/Sb2), where KD is the dissociation constant for
indo-1 and Ca
2+, R is the ratio of l1 and l2 at a specific time, Rmax
is the ratio of l1 and l2 after the cells are lysed with 0.1% Triton
x-100, Rmin is the ratio of l1 to l2 after treatment with 2 mM
EGTA, and Sf2/Sb2 is the ratio of free to bound dye as measured at
l2 [34,35].
Cytokine and chemokine measurements
Jurkat E6.1 T cells, HuT78 T cells, and APBTs were grown as
indicated above. The cells were washed in RPMI 1640 and
resuspended in complete RPMI 1640 media to a concentration of
1610
6 cells/mL. 0.5610
6 cells were then added to 24 well tissue
culture plates containing 2 mg/mL plate-bound OKT3 in the
absence or presence of 2 mg/mL soluble CD28 antibody or 1 mg/
mL human fibronectin. The cells were then incubated for
24 hours at 37uCi n5 %C O 2.
The presence of cytokines and chemokines in the media were
assessed using a human cytokine 30-plex luminex assay. Briefly, a
mixture of fluorescent beads, each containing an antibody to one of
30 different human cytokines or chemokines, were incubated with
standards of known quantities of each cytokine and chemokine or
supernatants from treated cells for two hours at RT. A mixture of
biotinylated antibodies to each cytokine or chemokine was added to
the beads for 1 hour at RT and then streptavidin labeled with the
fluorescent dye RPE was added for 30 minutes at RT. The amount
of bound streptavidin to each type of fluorescent bead was then
assessed using Bio-Rad Bio-Plex system.
The presence of IL-2 in the media was determined by standard
sandwich ELISA. Briefly, a monoclonal IL-2 antibody was coated
onto a RIA 96-well plate overnight at 4uC. Triplicates of IL-2
standards and supernatants from treated cells were then added to
the plate and incubated overnight at 4uC. A biotinylated
polyclonal IL-2 antibody was added to the plate for 2 hours at
RT and then streptavidin-horse radish peroxidase (HRP) was
added for 1 hour at RT. The amount of bound streptavidin was
then assessed using TMB peroxidase that was acidified using
0.67 N H2SO4. The absorbance of each well at 450 nM was then
measured using spectrophotometric plate reader.
Flow cytometry
Jurkat E6.1 T cells, HuT78 T cells, and APBTs were grown as
indicated above. The cells were washed in FACS Buffer (PBS with
10% fetal calf serum and 0.05% sodium azide) and resuspended in
FACS Buffer to a concentration of 1610
6 cells/mL. 0.5610
6 cells
were then incubated with isotype control or indicated primary
antibodies for 30 minutes on ice. The cells were washed in FACS
Buffer and again resuspended in FACS Buffer to a concentration
of 1610
6 cells/mL. The cells were then incubated with a PE-
labeled mouse IgG antibody for 30 minutes on ice. This step was
eliminated for the TCR a chain, CD3 and CD28 antibodies,
which were all directly conjugated to fluorescent dyes. The cells
were washed in FACS Buffer and again resuspended in FACS
Buffer to a concentration of 1610
6 cells/mL. The amount of
primary and secondary antibody bound to each cell was these
examined using a Becton Dickinson FACScan flow cytometer.
The flow cytometry data was then analyzed using the FloJo
analysis program. The percentage of positive cells were identified
by determining the percentage of cells with fluorescence .98% of
the isotype control. Mean fluorescence intensity was determined
using FloJo analysis program. The differences in TCR surface
expression was statistically compared between cell lines using a
two-tailed t-test assuming equal variance.
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